医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
2-氰基噻吩 | thiophene-2-carbonitrile | 1003-31-2 | C5H3NS |
|
2-氰基嘧啶-5-硼酸频那酯 | 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine-2-carbonitrile | 1025708-31-9 | C11H14BN3O2 |
|
2-氰基嘧啶 | 2-cyanopyrimidine | 14080-23-0 | C5H3N3 |
|
2-氰基喹啉-4-羧酸 | 2-cyanoquinoline-4-carboxylic acid | 408531-38-4 | C11H6N2O2 |
|
2-氰基哌嗪 | piperazine-2-carbonitrile | 187589-36-2 | C5H9N3 |
|
2-氰基吲哚 | 1H-indole-2-carbonitrile | 36193-65-4 | C9H6N2 |
|
2-氰基吡啶-4-醛 | 2-cyano-4-pyridinecarboxaldehyde | 131747-70-1 | C7H4N2O |
|
2-氰基吡啶-4-硼酸频哪醇酯 | 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinonitrile | 741709-62-6 | C12H15BN2O2 |
|
2-氰基吡啶-3-羧酸 | 2-cyanopyridine-3-carboxylic acid | 73112-09-1 | C7H4N2O2 |
|
2-氰基吡啶-3-硼酸新戊基乙醇酯 | 3-(5,5-dimethyl-[1,3,2]dioxaborinan-2-yl)picolinonitrile | 868944-75-6 | C11H13BN2O2 |
|
2-氰基吡啶-3-甲酸甲酯 | methyl 2-cyanonicotinate | 75358-89-3 | C8H6N2O2 |
|
2-氰基吡啶 | 2-Cyanopyridine | 100-70-9 | C6H4N2 |
|
2-氰基乙酰乙酸乙酯 | 2-cyanoethylacetoacetate | 65193-87-5 | C7H9NO3 |
|
2-氰基-N-(2,4-二氯-5-甲氧苯基)乙酰胺 | 2-cyano-N-(2,4-dichloro-5-methoxyphenyl)acetamide | 846023-24-3 | C10H8Cl2N2O2 |
|
2-氰基-N,N-二乙基乙酰胺 | 2-cyano-N,N-diethylacetamide | 26391-06-0 | C7H12N2O |
|
2-氰基-6-甲氧基哌嗪 | 2-Cyano-6-methoxypyridine | 136309-07-4 | C6H5N3O |
|
2-氰基-6-二甲基吡啶 | 3,6-dimethylpicolinonitrile | 68164-77-2 | C8H8N2 |
|
2-氰基-5-苄氧基嘧啶 | 5-benzyloxypyrimidine-2-carbonitrile | 166672-22-6 | C12H9N3O |
|
2-氰基-5-羧酰胺吡啶 | 2-Cyano-5-carboxamidopyridine | 14178-45-1 | C7H5N3O |
|
2-氰基-5-羟基嘧啶 | 5-hydroxypyrimidine-2-carbonitrile | 345642-86-6 | C5H3N3O |
|
2-氰基-5-羟基吡啶 | 5-hydroxypicolinonitrile | 86869-14-9 | C6H4N2O |
|
2-氰基-5-硝基吡啶 | 2-cyano-5-nitropyridine | 100367-55-3 | C6H3N3O2 |
|
2-氰基-5-甲氧基吡啶 | 5-methoxypicolinonitrile | 89809-63-2 | C7H6N2O |
|
2-氰基-5-甲基吡啶 | 5-methylnicotinonitrile | 42885-14-3 | C7H6N2 |
|
2-氰基-5-甲基吡啶 | 5-methylpicolinonitrile | 1620-77-5 | C7H6N2 |
|
2-氰基-5-溴甲基吡啶 | 5-(bromomethyl)picolinonitrile | 308846-06-2 | C7H5BrN2 |
|
2-氰基-5-氯嘧啶 | 5-chloropyrimidine-2-carbonitrile | 38275-56-8 | C5H2ClN3 |
|
2-氰基-5-氯吡啶 | 2-cyano-5-chloropyridine | 89809-64-3 | C6H3ClN2 |
|
2-氰基-5-氟溴苄 | 2-(bromomethyl)-4-fluorobenzonitrile | 421552-12-7 | C8H5BrFN |
|
2-氰基-5-氟嘧啶 | 5-fluoropyrimidine-2-carbonitrile | 38275-55-7 | C5H2FN3 |
|
2-氰基-5-氟吡啶 | 5-fluoropicolinonitrile | 327056-62-2 | C6H3FN2 |
|
2-氰基-5-吡啶硼酸 | (6-cyanopyridin-3-yl)boronic acid | 1011722-07-8 | C6H5BN2O2 |
|
2-氰基-5-三氟甲基吡啶 | 5-(trifluoromethyl)picolinonitrile | 95727-86-9 | C7H3F3N2 |
|
2-氰基-4-硝基吡啶 | 2-cyano-4-nitro-pyridine | 19235-88-2 | C6H3N3O2 |
|
2-氰基-4-甲基吡啶 | 2-Cyano-4-methylpyridin | 1620-76-4 | C7H6N2 |
|
2-氰基-4-甲基-5-硝基吡啶 | 4-methyl-5-nitropyridine-2-carbonitrile | 267875-30-9 | C7H5N3O2 |
|
2-氰基-4-吡啶羧酸甲酯 | methyl 2-cyanoisonicotinate | 94413-64-6 | C8H6N2O2 |
|
2-氰基-4-吡啶羧酸 | 2-cyanoisonicotinic acid | 161233-97-2 | C7H4N2O2 |
|
2-氰基-4-吡啶甲酰胺 | 2-cyano-4-aminoformyl-pyridine | 98273-47-3 | C7H5N3O |
|
2-氰基-4-吡啶甲酰肼 | 2-cyanoisonicotinohydrazide | 135048-32-7 | C7H6N4O |
|
2-氰基-4-叔丁基吡啶 | 6-<i>tert</i>-butyl-3-cyano-2-hydroxy-isonicotinic acid ethyl ester | 100616-09-9 | C13H16N2O3 |
|
2-氰基-4-三氟甲基吡啶 | 4-(trifluoromethyl)picolinonitrile | 936841-69-9 | C7H3F3N2 |
|
2-氰基-3-羟基喹啉 | 2-cyano-3-hydroxyquinoline | 15462-43-8 | C10H6N2O |
|
2-氰基-3-羟基吡啶 | 3-hydroxypyridine-2-carbonitrile | 932-35-4 | C6H4N2O |
|
2-氰基-3-硝基-5-氟吡啶 | 5-fluoro-3-nitropyridine-2-carbonitrile | 1033202-51-5 | C6H2FN3O2 |
|
2-氰基-3-甲氧基吡啶 | 3-methoxypicolinonitrile | 24059-89-0 | C7H6N2O |
|
2-氰基-3-甲基吲哚 | 3-methyl-1H-indole-2-carbonitrile | 13006-59-2 | C10H8N2 |
|
2-氰基-3-甲基吡啶 | 2-cyano-3-methylpyridine | 20970-75-6 | C7H6N2 |
|
2-氰基-3-甲基-5-羟基吡啶 | 5-hydroxy-3-methylpyridine-2-carbonitrile | 228867-86-5 | C7H6N2O |
|
2-氰基-3-甲基-5-氨基吡啶 | 5-amino-3-methylpyridine-2-carbonitrile | 252056-70-5 | C7H7N3 |
|